Six lots of 5 g-100 mL Adrucil (fluorouracil injection, USP) are being recalled over fears that the products may contain particulate matter and cause adverse effects, the U.S. Food and Drug Administration (FDA) reported on Friday, July 24.
Affected products have NDC number 0703-3019-11 for individual vials, and 0703-3019-12 for pharmacy shelf pack containing 5 vials. Lot numbers and the corresponding expiration dates are detailed in the FDA website. The defective intravenous products were sold to wholesalers, retailers, and pharmacies across the country.
Dangers of particulate matter in intravenous solutions include myocarditis (inflammation of the heart muscle), organ dysfunction, blood clot, and pulmonary embolism (blockage in one of the arteries of the lungs).
If you have been harmed by a defective medical product in Appleton, speak with our team at Habush Habush & Rottier S.C. ® to know if your circumstances make you eligible in filing a claim against the manufacturer involved. Call us at (414) 271-0900 for a free assessment of your situation today.